Search

A recent study conducted by the Department of Quality Assurance focused on developing and validating an analytical technique using RP-HPLC for the measurement of tartaric acid, sodium bicarbonate, sodium citrate, and tartaric acid granules. The researchers discovered that a reverse-phase and 210nm UV/visible detectors were effective for quantitative analysis. The optimal mobile phase was found to be (KH2PO4) 0.01M potassium dihydrogen phosphate with a pH of around 2.6, maintained with orthophosphoric acid. The study concluded that the RP-HPLC method using a C18 Shimadzu GIST Shim pack column achieved the best separation of tartaric acid, with a total analysis time of approximately 15 minutes. For more information, readers can refer to the article "An Updated Review on Analytical Method Validation of Tartaric Acid from Sodium Bicarbonate, Sodium Citrate, Citric Acid and Tartaric Acid Granules by RP-HPLC" published in the Asian Journal of Pharmaceutical Analysis. [Extracted from the article]

A recent study conducted at the Seventh Affiliated Hospital examined the relationship between baseline serum bicarbonate levels and the risk of postoperative delirium (POD) in patients undergoing cardiac surgery. The study analyzed data from the MIMIC-IV database and included 5,422 patients. The findings revealed that lower baseline serum bicarbonate levels were associated with a higher risk of POD. The researchers suggest that monitoring and adjusting serum bicarbonate levels could help identify high-risk patients and potentially improve outcomes. [Extracted from the article]

A patent application has been published online for a process that aims to reduce gastrointestinal discomfort in coffee drinkers. The process involves adding potassium bicarbonate to coffee beans or soluble coffee granules to decrease acidity and turbidity without affecting the taste. The application provides detailed instructions for creating low-acid coffee using potassium bicarbonate. This information may be useful for individuals studying gastroenterology or seeking alternative treatments for acid reflux. [Extracted from the article]

A patent has been issued for an intragastric device developed by Reshape Lifesciences Inc. The device is a volume-occupying balloon that can be inserted into the stomach by swallowing it, providing a feeling of fullness and reducing caloric intake. Unlike other devices, this device does not require invasive procedures or surgery. It can be inflated through a chemical reaction or by electrical or mechanical means, and deflation can be time-dependent or on-demand. The device aims to provide a noninvasive method for weight control and treating obesity. [Extracted from the article]

A study conducted at Wuhan University in China has explored the development of drug-free nanotherapeutics for cancer treatment. The researchers focused on using sodium bicarbonate nanoparticles to selectively induce non-apoptotic death in cancer cells through carbon dioxide-induced lysosomal rupture. The study found that this gas therapy approach resulted in cell death through necrosis, pyroptosis, and ferroptosis, rather than the conventional apoptosis pathway. The high water-solubility of sodium bicarbonate presented a challenge, but the researchers developed a water-tolerant nanoplatform that showed promising results in targeting and inhibiting tumors. This research may also provide insights into developing water-tolerant nanoparticles derived from water-soluble inorganic salts. [Extracted from the article]

A study conducted at the Federal University of Agriculture in Nigeria explored the synthesis of a porous scaffold made from eggshell-derived hydroxyapatite and ammonium bicarbonate for potential use in tissue engineering. The researchers analyzed the composition, size, functional groups, and morphology of the scaffold using various techniques. They found that the scaffold samples containing different amounts of ammonium bicarbonate had varying compressive stress levels and cytotoxicity effects on osteosarcoma cells. However, the cell adhesion studies showed instability and particle leaching in the media used. Further research is needed to address these issues. [Extracted from the article]

A patent has been issued to Entera Bio Ltd. for formulations and systems for oral administration of therapeutically active agents, such as proteins. The patent describes a pharmaceutical composition for oral administration that includes a therapeutically active agent, an antacid compound, and an absorption enhancer. The composition is formulated as a solid unit dosage form that is soluble in gastric fluid. This invention aims to address the challenges of degradation and poor absorption of large molecules in the digestive system. [Extracted from the article]

A recent study conducted at the University of Tubingen in Germany examined the response of Staphylococcus aureus to bicarbonate depletion. The researchers found that when the bacteria experienced a deficiency in bicarbonate and CO2, it resulted in changes in cell wall composition and global gene expression. These changes led to increased resilience to cell wall lytic enzymes and detergents. The study provides insights into the stress response of Staphylococcus aureus and its ability to adapt to environmental conditions. [Extracted from the article]

A recent study conducted in Hangzhou, China compared the use of lidocaine bicarbonate with fentanyl and chloroprocaine for epidural anesthesia during cesarean section. The study found that lidocaine bicarbonate combined with fentanyl had a slightly faster onset time and resulted in less hypotension compared to chloroprocaine. The research involved 102 women who underwent elective cesarean section and the primary outcome measured was the onset time to T6 block. The findings suggest that lidocaine bicarbonate with fentanyl may be a more effective option for epidural anesthesia during cesarean section. [Extracted from the article]

A study conducted by researchers at the University of Verona in Italy explored the relationship between serum bicarbonate (SBC) levels and mortality in patients with advanced chronic kidney disease (CKD). The study analyzed data from the EQUAL cohort, which included patients aged 65 years and older with an estimated glomerular filtration rate (eGFR) of 20 ml/min per 1.73 m2 from six European countries. The researchers found a U-shaped relationship between SBC levels and all-cause mortality in the pre-kidney replacement therapy (KRT) population, indicating that both low and high SBC levels were associated with increased mortality risk. In the KRT population, low SBC levels showed a trend towards increased mortality risk. The study also observed effect modification by subjective global assessment (SGA) category and KRT. Overall, the findings suggest that SBC levels may be a useful marker for mortality risk in patients with advanced CKD. [Extracted from the article]

A report from Boehringer Ingelheim Pharma GmbH & Co. KG explores the release profiles of the antiviral drug ritonavir from amorphous solid dispersions (ASDs). The study compares the release rates of ritonavir from ASDs with different buffer properties and evaluates its bioaccessibility. The research finds that the release of ritonavir is controlled by the polymer in all buffer systems tested, with slower release in bicarbonate buffers and faster release in phosphate buffers. The study highlights the need for the development of biorelevant assays for assessing ASD formulations. [Extracted from the article]

The article discusses new insights into chronic kidney disease (CKD) from research at Chi Mei Medical Center, focusing on the effects of sodium bicarbonate treatment. Topics include the improvement in kidney function and muscle mass associated with sodium bicarbonate, the increased risk of elevated systolic blood pressure, and the overall need for further research due to some study limitations.

The article focuses on the role of DRA (SLC26A3) in bicarbonate secretion stimulated by linaclotide in the context of cystic fibrosis (CF). Topics include the impact of linaclotide on bicarbonate secretion in CF and non-CF models, the involvement of DRA in this process, and the potential therapeutic benefits of linaclotide for CF patients with impaired bicarbonate secretion.

The article offers information on a study evaluating the impact of bicarbonate-rich water and diet on acid-base balance and anaerobic performance. Topics discussed include the effects of bicarbonate-rich water on blood and urine pH; the interaction of alkalizing and acidizing diets with bicarbonate intake; and the study's findings on anaerobic performance.

A recent report discusses research findings on brain injury and central nervous system diseases and conditions. The study focuses on the use of preservatives for postmortem brain tissue in biomechanical testing. The researchers explored the effects of potential preservatives on brain tissue breakdown and identified sodium bicarbonate as a promising preservative that may slow postmortem degradation. The study suggests that sodium bicarbonate has the potential to reduce the deterioration of brain tissue in biomechanical testing, which could improve understanding of brain injury mechanisms. Further investigation is needed to evaluate sodium bicarbonate as a preservative under different test conditions. [Extracted from the article]

A patent has been issued to Azurity Pharmaceuticals Inc. for compositions and kits for Omeprazole suspension. The patent describes a liquid formulation for preparing an Omeprazole Powder for Oral Suspension Kit, which can be used to treat acid-related disorders. The formulation is stable and can be stored for up to 24 months. It contains ingredients such as poloxamer, sodium carboxymethylcellulose, sodium bicarbonate, and a sweetener. The liquid diluent is freeze-thaw stable and can be stored for at least 30 days. This patent provides a solution for patients who are unable to swallow solid dosage forms of medication. [Extracted from the article]

A recent report from the University of Trieste in Italy discusses the treatment of acidosis in a patient with Kearns-Sayre disease. Acidosis is a common manifestation of mitochondrial diseases and can be challenging to manage, especially in pediatric patients. The researchers describe the case of a girl with severe renal tubular acidosis who showed persistent low levels of serum bicarbonates despite oral supplementation. They found that administering bicarbonates through percutaneous gastrostomy with continuous nocturnal infusion significantly improved the patient's electrolyte control and quality of life. This approach may be a valuable solution for correcting metabolic acidosis, particularly in pediatric settings where compliance with oral therapy is often difficult. [Extracted from the article]

A recent study conducted by researchers from Eskisehir Technical University investigated the effects of caffeine and sodium bicarbonate on strength performance. The study involved nineteen male college students who were given different supplements or placebos before performing the isometric mid-thigh pull test (IMTP). The results showed that caffeine supplementation alone, taken 60 minutes before exercise, positively affected submaximal strength performance. However, sodium bicarbonate, whether taken alone or in combination with caffeine, did not enhance submaximal strength in the IMTP tests. [Extracted from the article]

A new report from Kawashima Hospital presents fresh data on hemodialysis. The research compares mortality rates between acetate-containing bicarbonate dialysate (ABD) and acetate-free bicarbonate dialysate containing citrate (AFD) in hemodialysis patients. The study found that in patients on super high-flux (SHF) and SHF albumin-leaking hemodialysis, ABD was associated with higher mortality rates compared to AFD. However, this difference was not observed in patients undergoing online hemodiafiltration (OHDF). The findings suggest that ABD may worsen mortality in certain hemodialysis patients. [Extracted from the article]

A patent has been issued for the synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds. The patent discusses the use of ketogenic diets and ketone bodies for the treatment of various human disorders, such as epilepsy and dementia. The primary ketone bodies in humans are acetoacetate and b-hydroxybutyrate, with the R-enantiomer of b-hydroxybutyrate being of particular interest. The patent also describes the energy and signaling functions of b-hydroxybutyrate and provides methods for its synthesis. The assignee for this patent is the Buck Institute for Research on Aging. [Extracted from the article]

A patent has been issued for a ready-to-use diclofenac formulation developed by APR Applied Pharma Research SA. The formulation is a liquid, single-dose oral solution containing diclofenac potassium as the active ingredient. It includes an alkalizing agent to adjust the pH, and a sugar-based aqueous solution for solubilization and stabilization. The formulation has been shown to be chemically and physically stable, even under accelerated degradation conditions. This patent provides a new dosage form for diclofenac, offering convenience to patients and potential therapeutic benefits. [Extracted from the article]

A patent application has been submitted for a dosing regimen to treat nasal cavity and pharynx congestion. The inventor proposes a composition formulated as an aqueous solution containing sodium bicarbonate, with the dosing regimen involving administering a first dose followed by a second dose. The inventor claims that this regimen provides safe and effective decongestion without the adverse side effects of existing treatments. The patent application includes various claims and methods for administering the composition. [Extracted from the article]

A recent study conducted by the University of Colorado examined the utilization of medications for cardiac resuscitation in emergency departments across the United States. The study found that vasoactive medications, which help maintain hemodynamic goals, are commonly used during advanced cardiac life support (ACLS) and after return of spontaneous circulation (ROSC). The survey also revealed that epinephrine dosing and administration during cardiac arrest were generally in accordance with ACLS algorithms. Norepinephrine was the most commonly used vasopressor for post-ROSC hypotension. The study provides valuable insights into medication practices in emergency departments and highlights the need for further research in this area. [Extracted from the article]

Researchers from the University of Iowa Hospitals and Clinic have conducted a study on the use of an alternative purge solution for patients with an Impella ventricular assist device undergoing PET scans. The study found that a sterile water-based bicarbonate purge solution, with a short-term restriction of dextrose, was a practical option for PET imaging in these patients. The solution did not have any adverse effects on pump function. This research has been peer-reviewed and published in the American Journal of Health-System Pharmacy. [Extracted from the article]

A patent application has been submitted for a new ready-to-use ascorbic acid compound composition. Ascorbic acid, also known as vitamin C, is important for health and is used to treat vitamin C deficiency and scurvy. The current products on the market need to be diluted before use and stored in a refrigerator. The new composition aims to provide a convenient and stable form of ascorbic acid that does not require dilution and can be stored at room temperature for a long time. It may also contain additional ingredients like stabilizers, buffers, and antioxidants. The patent application describes these compositions for the treatment of scurvy, including their components and methods of use. [Extracted from the article]

A patent application has been filed for a new ready-to-use ascorbic acid compound composition, which is also known as vitamin C. Ascorbic acid is important for health and is used to treat various diseases and conditions caused by vitamin C deficiency. Currently, ascorbic acid formulations for intravenous use need to be diluted and stored in the refrigerator. This invention aims to create a convenient and stable ready-to-use composition of ascorbic acid that does not require dilution and can be stored at room temperature for a long time. The composition may also include other substances like stabilizing agents, buffers, and antioxidants. The patent application describes these compositions for the treatment of scurvy, and specifies the concentrations of the components and the stability of the compositions. The goal of this invention is to provide effective and stable treatments for scurvy. [Extracted from the article]

A recent study conducted by researchers at the University of California San Diego (UCSD) has found that the administration of bicarbonate can protect mitochondria, rescue retinal ganglion cells (RGCs), and improve visual dysfunction caused by oxidative stress. The study focused on the role of the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling pathway and soluble adenylyl cyclase (sAC) in mitochondrial protection and RGC survival. The findings suggest that activating sAC can enhance mitochondrial structure and function in RGCs, providing potential therapeutic benefits for treating glaucoma and other retinal diseases. [Extracted from the article]

A recent study conducted at Charite University Hospital and School of Medicine in Berlin, Germany, explored the use of pCO(2)-adapted continuous kidney replacement therapy (CKRT) for hypercapnic acute respiratory distress syndrome (ARDS) patients. The study aimed to determine the feasibility, safety, and clinical benefits of this approach. The researchers found that tailoring CKRT to physiological renal compensation of respiratory acidosis was feasible and safe, with the potential to improve patient care in hypercapnic ARDS. The study's findings suggest a new approach to CKRT protocols for these patients. [Extracted from the article]

A study conducted by researchers at the University of Bucharest in Romania has revealed new findings on the degradation of the antibiotic Epirubicin in hospital wastewater. The researchers propose a cost-efficient and environmentally friendly system for the degradation of Epirubicin using cobalt-catalyzed bicarbonate-activated peroxide. They identified seven degradation products and found that the presence of a specific surfactant increased the degradation rate. The study also showed a decrease in toxicity of the degradation products. The same system was also successful in degrading other drugs. [Extracted from the article]

A patent has been issued to Diality Inc. for a disposable cartridge and pump track mechanism for use in hemodialysis. Hemodialysis is a medical procedure that removes waste products from a patient's blood by diffusing solutes across a semipermeable membrane. The dialysis machine includes a dialyzer with hollow fibers that separate the blood plasma from the dialysate, allowing waste to permeate into the dialysate. The patent describes a dialysis system that includes a disposable cartridge with tubing lines and a housing, as well as a dialysis machine with a frame, cassette, and actuation mechanism. The cartridge and machine are designed to securely connect and facilitate the dialysis process. This invention aims to address the drawbacks of current hemodialysis systems, such as size, complexity, and cost, and make home hemodialysis more feasible. [Extracted from the article]

A systematic review conducted by researchers at the European University of Madrid evaluated the effectiveness of various nutritional ergogenic aids in the context of cycling. The review included 36 articles involving 701 participants and examined the effects of supplementation with caffeine, creatine, sodium bicarbonate, beta-alanine, and nitrates, both individually and in combination. The findings indicated that caffeine supplementation had a positive impact on athletic performance in cyclists, and there was a potential positive effect observed with sodium bicarbonate and the combination of caffeine and creatine. However, no statistically significant effects were found for the other supplements. This research provides valuable insights for individuals interested in enhancing their cycling performance through nutritional ergogenic aids. [Extracted from the article]

A patent has been issued for abuse-deterrent dosage forms containing esketamine. The patent describes oral dosage forms that include core-shell particles and a matrix, which are designed to discourage abuse and overdosing of the active pharmaceutical ingredient. The dosage forms exhibit both immediate release and extended release profiles of esketamine, depending on the dose administered. The patent also includes methods of manufacturing the dosage forms and reducing the potential for abuse. The patent was filed by Clexio Biosciences Ltd. and published online on May 28, 2024. [Extracted from the article]

A recent study conducted by researchers at the University of Nebraska Medical Center investigated the use of sodium bicarbonate in the management of metabolic acidemia in neonates with hypoxic-ischemic encephalopathy (HIE). The study found that there was a higher mortality rate and increased injury on MRI scans in the group that received bicarbonate compared to the control group. However, when adjusting for certain factors, the combined outcome of death or abnormal MRI was not significantly associated with bicarbonate administration. The researchers concluded that future prospective trials could provide more conclusive results. [Extracted from the article]

A patent has been issued for a liquid creamer that can be used in hot and cold beverages such as coffee, cocoa, malt beverages, and tea. The creamer is designed to provide whitening, body, and a smooth texture, and it should remain stable without phase separation or undesirable flavors. The inventors have developed a liquid creamer formula that includes casein-based protein, pea protein, gellan gum, bicarbonate, citrate, and oil. This combination of ingredients provides good shelf life stability and does not compromise the texture or whitening capacity of the creamer when added to hot beverages. The creamer can also be used with water of varying hardness levels. The patent was filed by Societe des Produits Nestle S.A. and published online on May 28, 2024. [Extracted from the article]

A new report discusses research on hemodialysis conducted at McMaster University in Canada. The study aimed to examine the association between the dialysate bicarbonate prescription and the pre-dialysis serum bicarbonate concentration. The researchers found that there was no significant difference in the pre-dialysis serum bicarbonate concentration whether an individualized or standardized dialysate bicarbonate was used. However, dialysate bicarbonate concentrations of 38 mmol/L (compared to 35 mmol/L) may increase the pre-dialysis serum bicarbonate concentration by 0.9 mmol/L. [Extracted from the article]

A recent preprint abstract discusses the cryo-electron microscopy structure of the bicarbonate receptor GPR30. The study reveals the mechanisms by which GPR30 interacts with bicarbonate ions and identifies critical residues for bicarbonate binding and activation. The findings not only advance the understanding of GPR30's role in pH homeostasis but also have implications for the development of high-affinity drugs targeting GPR30 for therapeutic interventions in diseases associated with acid-base imbalance. It is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted by researchers at the University of Utah explores the relationship between metabolic acidosis and chronic kidney disease (CKD). Metabolic acidosis, a common complication of CKD, is associated with various negative outcomes such as deteriorating kidney function, cardiovascular events, and even death. The researchers suggest that providing alkali, particularly sodium bicarbonate, may disrupt the cycle of acid accumulation and acid-mediated kidney injury, potentially preserving kidney function and mitigating the adverse effects of excess acid on bone and muscle. However, the results of clinical trials on this intervention have been conflicting, and further well-powered trials are needed to determine its efficacy and safety. [Extracted from the article]

A patent application has been filed for a dosing regimen that aims to provide safe and effective nasal and pharynx decongestion. The regimen involves administering a first dose of an aqueous solution containing sodium bicarbonate to the patient, followed by a second dose. The composition is formulated to alleviate congestion without causing adverse side effects. The patent application includes various claims related to the dosing regimen, including the use of different administration methods and additional ingredients. [Extracted from the article]

A recent study conducted at the Second Affiliated Hospital of Anhui Medical University compared the use of bicarbonate Ringer's solution and lactated Ringer's solution in patients who underwent laparoscopic right hemihepatectomy. The study found that patients who received bicarbonate Ringer's solution had improved outcomes, including lower lactic acid concentrations, improved pH levels, and better liver function. Additionally, these patients had a shorter hospital stay and a lower incidence of complications. The study was registered at clinicalTrials.gov and more information can be obtained from the Department of Anesthesiology at the Second Affiliated Hospital of Anhui Medical University. [Extracted from the article]

A recent study conducted by researchers at Air Force Medical University in Beijing, China, explored the association between serum bicarbonate levels and mortality in patients with acute kidney injury (AKI). The study analyzed data from 4,800 AKI patients and found a U-shaped relationship between serum bicarbonate levels and mortality, with the lowest mortality rate observed at a level of 26.9 mmol/L. Patients with higher bicarbonate levels also had lower rates of ICU admission and shorter hospital stays. The researchers suggest that further prospective clinical studies are needed to determine if optimizing serum bicarbonate levels can decrease mortality in this population. [Extracted from the article]

A recent study conducted by researchers at Aix-Marseille University in Marseille, France, explores the recrystallization of sodium bicarbonate using the Supercritical AntiSolvent process. The study focuses on the crystal habit and how it can be modified by changing the solvent nature. The researchers observed an uncommon crystal shape, referred to as a 'zigzag' shape, and determined that it was not due to particle attachment but rather the result of monocrystals grown in a diffusion-limited media. Molecular modeling studies revealed that certain organic solvents, such as ethylene glycol and glycine, interact strongly with sodium bicarbonate crystals, while others, like ethanol or water, interact weakly. Experimental confirmation of these interactions led to the production of a different crystal salt when ethylene glycol was used. The addition of glycine as a growth inhibitor also resulted in the initial polymorphic form of the crystal, albeit with a modified growth mechanism. This research provides new insights into crystal growth processes and their potential applications in the field of life science. [Extracted from the article]

According to a preprint abstract from biorxiv.org, researchers have found that linaclotide, a medication used to treat constipation, may also stimulate duodenal bicarbonate secretion. This is important because duodenal bicarbonate secretion is critical for epithelial protection and nutrient digestion/absorption, but it is impaired in individuals with cystic fibrosis (CF). The study found that linaclotide increased bicarbonate secretion in both mouse and human duodenum, even in the absence of CFTR expression or function. The researchers also identified a chloride/bicarbonate exchanger called down-regulated in adenoma (DRA) that may compensate for the loss of CFTR in regulating luminal pH. These findings suggest that linaclotide may be a useful therapy for CF individuals with impaired bicarbonate secretion. However, it is important to note that this preprint has not been peer-reviewed. [Extracted from the article]

A recent study conducted by researchers at Yunnan Agricultural University in China has found that pre-soil fumigation with ammonium bicarbonate and lime can effectively manage clubroot disease in Chinese cabbage. The researchers discovered that this method reduced disease incidence by decreasing soil acidity and the population of the pathogen responsible for clubroot disease. Additionally, the fumigation altered the composition and diversity of the rhizosphere microbiome. The study concludes that this environmentally friendly approach can play a crucial role in mitigating clubroot disease and promoting sustainable agriculture. [Extracted from the article]

A recent report from B&B Hospital in Nepal discusses the treatment of diabetic ketoacidosis (DKA), a life-threatening complication of diabetes. The report emphasizes the importance of managing DKA with intravenous fluids, insulin, and potassium, but notes that bicarbonate therapy is generally not recommended due to unfavorable outcomes. The report presents a case study of a 21-year-old female patient with DKA who was successfully managed without the need for bicarbonate therapy. The research concludes that adherence to medication and proper hydration are crucial in managing DKA, while bicarbonate therapy does not offer any beneficial effects. [Extracted from the article]

A recent study conducted by researchers at Mahidol University in Bangkok, Thailand, explored the efficacy of two different abrasive powders, sodium bicarbonate and erythritol, in removing biofilm from dental implant surfaces. The study found that both powders were effective in removing biofilm under ideal conditions, with no significant difference in their cleaning potential. These findings suggest that regular maintenance with mechanical debridement using air abrasion therapy and these powders could help prevent peri-implantitis, a common complication in implant therapy that can lead to implant failure. Further research is needed to explore the long-term effects of this treatment. [Extracted from the article]

A study conducted by researchers from Ritsumeikan University in Shiga, Japan, explored the impact of buffer species on the dissolution behavior of orally disintegrating tablets (ODT) containing a basic polymer and its influence on bioequivalence (BE) prediction. The study used fexofenadine hydrochloride ODT formulations as the model formulations, with Allegra as the reference formulation and generic formulations A and B as the test formulations. The dissolution tests were conducted using bicarbonate and phosphate buffers, and the results indicated that the use of bicarbonate buffer may offer a more precise prediction of human bioequivalence compared to phosphate buffer. [Extracted from the article]

A patent has been issued to the University of North Carolina at Chapel Hill for methods and compositions for treating mucosal tissue disorders. The invention involves pharmaceutical compositions containing glutathione, ascorbate, and bicarbonate, which can be used to treat diseases and disorders in mucosal/epithelial tissue. The compositions can be administered through inhalation and may be effective in reducing bacterial growth and inflammation in the airways. This patent provides potential therapeutic approaches for conditions such as cystic fibrosis, asthma, and chronic obstructive pulmonary disease. [Extracted from the article]